rcc: current applications, controversies, and future use of immunotherapy and targeted agents
Published 3 years ago • 110 plays • Length 1:03:29Download video MP4
Download video MP3
Similar videos
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
1:28:18
navigating evolving standards of care in rcc: novel targeted and immunotherapy options
-
1:16:25
rcc masterclass and clinical consult: novel immune and targeted therapies
-
55:12
selecting and sequencing targeted and immunotherapy regimens for patients with rcc
-
54:37
optimizing patient outcomes in rcc through safe use of immuno-oncology and targeted approaches
-
1:37:34
nursing strategies for rcc: optimizing outcomes with novel targeted and immune-based therapies
-
4:46
immunotherapy in rcc: current status and future directions
-
1:37:52
updating our cardio-oncology skills in the cancer immunotherapy era: management of cardiac iraes
-
1:38:51
clinically meaningful outcomes among expanding treatment options in rcc
-
33:06
maximizing the of potential current and emerging immunotherapies in advanced endometrial cancer
-
1:03:39
deep insight into immuno-oncology: immunotherapy pathways, targets, and biomarkers
-
1:02:22
individualizing rcc therapy in the era of immuno-oncology
-
1:14:51
the present and the future of cancer immunotherapy biomarkers
-
56:08
gaining confidence in predicting and assessing response to cancer immunotherapies
-
1:26:59
progress in immunotherapy biomarker testing and pathologic response assessment in solid tumors
-
1:29:06
leveraging neoadjuvant and adjuvant immunotherapy to improve outcomes in early-stage cancers
-
55:16
targeting tigit to extend immunotherapy benefits to more cancer patients
-
1:28:17
getting personal with advanced btc
-
1:18:10
new frontiers in precision immuno-oncology